Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 12, 2024
BOSTON and LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients, today reported financial results for the third quarter ended September 30, 2024, and provided a business update.
Read more at globenewswire.com
